Treatment of chronic hemodialysis patients with low-dose fenofibrate effectively reduces plasma lipids and affects plasma redox status

Dyslipidemia is common in chronic hemodialysis patients and its underlying mechanism is complex. Hemodialysis causes an imbalance between antioxidants and production of reactive oxygen species, which induces the oxidative stress and thereby may lead to accelerated atherosclerosis. Statins have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Makówka, Agnieszka, Dryja, Przemysław, Chwatko, Grażyna, Bald, Edward, Nowicki, Michał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390906/
https://www.ncbi.nlm.nih.gov/pubmed/22564753
http://dx.doi.org/10.1186/1476-511X-11-47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390906/
https://www.ncbi.nlm.nih.gov/pubmed/22564753
http://dx.doi.org/10.1186/1476-511X-11-47

Ejemplares similares